Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for auto industry professionals · Monday, February 24, 2025 · 788,761,021 Articles · 3+ Million Readers

Global Endocrinology Drugs Market Outlook 2025-2034: Growth Drivers, Share, And Trends

Endocrinology Drugs Global Market Report 2025

Endocrinology Drugs Global Market Report 2025

The Business Research Company's Endocrinology Drugs Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034

LONDON, GREATER LONDON, UNITED KINGDOM, February 24, 2025 /EINPresswire.com/ -- Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

Is The Endocrinology Drugs Market Anticipated To Grow In The Future?
Indeed, the endocrinology drugs market size is expected to see strong growth in the future. It is forecasted to leap to $50.37 billion by 2029 at a CAGR of 8.60%. This predicted surge during the forecast period can be attributed to a surge in the diabetic population, increased incidences of endocrine disorders, a rising number of adolescents with hormonal imbalances, and escalating obesity rates. Pivotal trends during this period include technological advancements, adoption of advanced drug delivery systems, integration of digital health solutions, precision medicine, and combination therapies.

How Do Endocrinology Drugs Help In Managing Endocrine Diseases?
The rising prevalence of endocrine diseases is a notable factor propelling the growth of the endocrinology drugs market. Endocrine diseases disrupt the endocrine system, interfering with normal hormone regulation or production, which can affect normal bodily functions. Factors such as lifestyle changes, aging population, and improved diagnosis have boosted the recognition and incidence of these conditions. Endocrinology drugs manage endocrine diseases by regulating hormone levels, resolving glandular dysfunction, and restoring hormonal balance to relieve symptoms and improve overall health outcomes. As of May 2023, according to the US-based National Library of Medicine, approximately 13 million people, or 4.78% of the US population, suffered from undiagnosed endocrine disorders. Among these, thyroid disease was one of the most prevalent, accounting for roughly 30% to 40% of patients treated in endocrine practices. This indicates how crucial endocrinology drugs are in managing these disorders, and how their importance is driving the market's growth.

Get Your Free Sample Market Report: https://www.thebusinessresearchcompany.com/sample.aspx?id=20769&type=smp

Who Are The Major Players In The Endocrinology Drugs Market?
Major companies operating in the endocrinology drugs market include Johnson & Johnson Inc., Merck & Co. Inc., AbbVie Inc., Bayer Aktiengesellschaft, Novartis International AG, Sanofi S.A., AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Biocon Limited, Boehringer Ingelheim International GmbH, Mylan N.V., Sandoz International GmbH, Ipsen Pharma, Ferring Pharmaceuticals Inc., Endocrine Pharma Private Limited.

What Are The Emerging Trends In The Endocrinology Drugs Market?
Key players in the endocrinology drugs market are focusing on innovative products such as ready-to-use vials to improve medication administration. These vials, which are pre-filled and pre-dosed, require no preparation before administration, providing convenience and safety. For instance, in December 2022, Hikma Pharmaceuticals plc, a UK-based pharmaceutical company, launched Levothyroxine sodium injection in ready-to-use vials at a concentration of 100 mcg/mL. This immediately usable formulation eliminates the need for reconstitution, reducing the risk of preparation errors, and improving patient safety. This useful innovation is expected to drive market growth.

Order Your Report Now For A Swift Delivery: https://www.thebusinessresearchcompany.com/report/endocrinology-drugs-global-market-report

How Is The Endocrinology Drugs Market Segmented?
By Indication: Hyperthyroidism, Hypothyroidism, Diabetes, Polycystic Ovarian Syndrome, Growth Hormone Disorders, Pituitary Gland Disorders, Other Indications
By Therapy Area: Diabetes Drugs, Thyroid Hormone Disorder Drugs, Human Growth Hormone, Testosterone Replacement Therapy, Others Therapy Areas
By Distribution Channel: Hospital pharmacies, Online Pharmacies, Retail pharmacies
By End User: Hospitals, Ambulatory Surgical Centers, Others End Users

Further, it has subsegments:
By Hyperthyroidism: Antithyroid Medications, Radioactive Iodine Therapy, Beta Blockers
By Hypothyroidism: Levothyroxine-based Medications, Liothyronine-based Medications, Combination Hormonal Therapies
By Diabetes, and more

What Are The Regional Insights Of The Endocrinology Drugs Market?
North America was the largest region in the endocrinology drugs market in 2024, but Asia-Pacific is expected to be the fastest-growing region during the forecast period. Other regions covered in the market report include Western Europe, Eastern Europe, South America, the Middle East, and Africa.

Browse For More Similar Reports-

Acute Pancreatitis Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/acute-pancreatitis-global-market-report

Pancreatic Cancer Diagnostic Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/pancreatic-cancer-diagnostic-global-market-report

Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/exocrine-pancreatic-insufficiency-epi-therapeutics-and-diagnostics-global-market-report

About The Business Research Company:
The Business Research Company boasts a repository of over 15000+ reports spanning 27 industries and 60+ geographies. It prides itself on comprehensive, data-rich research and insights. Armed with 1.5 million datasets, in-depth secondary research, and unique insights from industry leaders, it provides valuable data that helps you to stay ahead in the game.

Get in touch:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us: info@tbrc.info

Stay connected:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn

Powered by EIN Presswire

Distribution channels: Business & Economy, Companies, Healthcare & Pharmaceuticals Industry, International Organizations, World & Regional

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Submit your press release